• Skip to main content
  • Skip to primary sidebar

SpotGamma™

S&P 500 Stock Market Gamma Trading Levels Based on Options Open Interest

  • About
  • Pricing
  • Academy
  • Resources
    • Tool Demos
    • Case Studies
    • Blog
    • Support Center
    • Daily Report
    • Free Trading Tools
      • Opening Setup Free Report
      • Options Profit Calculator
      • SPX Gamma Exposure
      • Implied Earnings Moves
    • Free Training
    • Report Card
  • Login

SpotGamma Weekly

Jan 11 2026

Vol Stays Quiet as SPX Reaches All-Time Highs

Dual-line chart tracking SPX implied volatility over time with annotation marking current position in early January 2026.

Strong 0DTE Support Lifts the Market to Record Highs The S&P 500 kicked off 2026 by grinding through a week of macro data releases to finish at fresh all-time highs on Friday. SPX closed at 6,966, up from the 6,902 open on Monday, after finding critical support in the 6,890–6,900 zone multiple times throughout the […]

Written by Simon Scholten · Categorized: Market Analysis, SpotGamma Weekly · Tagged: iv, OPEX, positive gamma, spotgamma weekly, SPX, trade example, volatility

Jan 04 2026

Record 0DTE volume reshapes the S&P 500

Dual-line chart tracking SPX implied volatility over time with annotation marking current position in early January 2026.

Record 0DTE Volume in 2025 Has Changed the Game We wrapped up 2025 with the S&P 500 up 18% for the year—a solid result in the face of tariff headlines, global conflicts, and inflation concerns. One of the major options market stories of the past year has been the growing role of 0DTE options: same-day expiration […]

Written by Simon Scholten · Categorized: Market Analysis, SpotGamma Weekly · Tagged: holiday, iv, negative gamma, OPEX, spotgamma weekly, SPX, trade example

Dec 21 2025

Subdued Volatility and the Setup Into Year-End

SPX put spread payoff diagram showing profit/loss across stock prices with Greeks and expiration details.

Subdued Vol Meets Negative Gamma Weakness in AI-related stocks dominated market headlines last week, most notably for Oracle and Broadcom. This pushed the market downward, before the rebound on Thursday and Friday. Despite the market trending down for three consecutive days, implied volatility remained surprisingly subdued: put skew remained average, and ATM implied volatility sat […]

Written by Simon Scholten · Categorized: Market Analysis, SpotGamma Weekly · Tagged: holiday, iv, negative gamma, OPEX, spotgamma weekly, SPX, trade example

Dec 14 2025

FOMC Reset: Vol Crushes, Stocks Lift Higher

SPX gamma chart showing strike levels around 6,800-7,000 with total gamma bars and trend lines.

Last week began with quiet anticipation of Wednesday’s FOMC. When the Fed announced the 25 basis point rate cut and Treasury bill purchases, the reaction was immediate. Equities surged, with the SPX breaking out above our 6,845 Volatility Trigger to approach all-time-highs near the 6,900 resistance level. The options market had priced in meaningful event-related volatility surrounding FOMC, and […]

Written by Simon Scholten · Categorized: Market Analysis, SpotGamma Weekly · Tagged: 0DTE, FOMC, forward-vol, iv, negative gamma, OPEX, spotgamma weekly

Dec 07 2025

How the Options Market is Positioning for FOMC

Four-quadrant Compass chart plotting tickers like HYG, IWM, TLT and LQD in cheap volatility upside potential over 5 days.

Markets hovered near all-time highs last week as traders eagerly await next week’s FOMC. The SPX traded in a tight 6,800-6,900 range, while volatility compressed to multi-month lows: VIX dropped 15% this week to 15.4, experiencing some of the lowest values since September. This is a trend we’re watching closely: Softer demand for volatility (options) […]

Written by Simon Scholten · Categorized: Market Analysis, SpotGamma Weekly

Nov 30 2025

FOMC in Focus After Market’s Thanksgiving Feast

SPX implied volatility line chart by expiration date with PCE, FOMC and OPEX marked.

Post-OPEX Dynamics Drive Thanksgiving Week Rally The shortened Thanksgiving holiday week delivered exactly what we outlined in our Monday morning Founder’s Note: a powerful post-OPEX rally driven by put option decay and volatility compression. The week marked a significant bullish pivot for U.S. equities, with the S&P 500 rallying from 6,636 to 6,849—a gain of over […]

Written by Simon Scholten · Categorized: Market Analysis, SpotGamma Weekly

Nov 23 2025

Negative Gamma Fuels Extreme Volatility

SpotGamma GEX by strike chart highlighting 0DTE in green, price line at 6642 over a gamma heatmap.

There’s really only one way to summarize the past few days: “What a week!” Markets delivered some of the most extreme intraday swings of the year, culminating in Thursday’s violent selloff and Friday’s equally dramatic reversal—one of the sharpest two-day sequences we’ve seen in 2025. As of Thursday, the S&P 500 was on track for the worst […]

Written by Simon Scholten · Categorized: Market Analysis, SpotGamma Weekly

Nov 16 2025

All Eyes on NVDA as Volatility Spikes

SPX gamma exposure chart displaying total gamma bars and line across strikes, highlighted at 6330 and 7000.

From Market Euphoria to “Elevator Down” Markets experienced a dramatic reversal last week. Monday began with bullish momentum after the government shutdown deal was reached, yet by Thursday the market was facing intense selling pressure. Notably, SPX broke below the critical 6,800 risk pivot level we emphasized daily in our Founder’s Notes, triggering higher volatility. As […]

Written by Simon Scholten · Categorized: Market Analysis, SpotGamma Weekly

Nov 09 2025

SPX Down, Vol Up: What Makes Last Week’s Selloff Different

SPX implied volatility vs strike prices line chart with two curves, $6,740.5 current price, yellow arrows.

The market experienced a meaningful shift this week as SPX declined nearly 3% from the all-time highs of October 29, closing Friday at 6,729. What began as fluid, transient price action evolved into more concerning market dynamics by the end of the week. The week’s volatility behavior differed markedly from the tariff-induced selloff on October […]

Written by Simon Scholten · Categorized: Market Analysis, SpotGamma Weekly

Nov 02 2025

The Market’s Balancing Act: Euphoria vs. Anxiety

Candlestick chart of S&P 500 showing a sharp drop after Powell's hawkish comments.

Last week, SPX tested all-time highs at 6,920 while also reaching lows near the key gamma strike of 6,815 — a journey that balanced euphoria and anxiety. Wednesday morning began with a major risk alert from our AM Founder’s Note, which was validated over the next two days: the combination of the “spot up, vol up” […]

Written by Simon Scholten · Categorized: Market Analysis, SpotGamma Weekly

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Go to page 7
  • Go to Next Page »

Primary Sidebar

SpotGamma-Subscriber-Signup-Banner

  • Rising Correlation Is Thinning Out The Rotation Trade
  • Tech Selloff Looks Like Rotation: Brent Kochuba on Schwab Network
  • META Earnings Preview: Will Volatility Outrun the Options Market?
  • Traders Are Bidding The Put Wing Without Paying For Vol: Brent Kochuba On tastylive
  • Tesla & SpaceX Earnings Preview: Two Reports, One Merger Question — What Are Options Pricing?
  • youtube
  • x
  • Privacy Policy
  • Disclaimer
  • Terms & Conditions
  • Support Center
  • Media
  • Contact Us

©2026 TenTen Capital LLC DBA SpotGamma

All SpotGamma materials, information, and presentations are for educational purposes only and should not be considered specific investment advice nor recommendations. Futures, foreign currency and options trading contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing one's financial security or lifestyle. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. Testimonials appearing on this website may not be representative of other clients or customers and is not a guarantee of future performance or success.

View Full Risk Disclosure